Tanja Hakkarainen - Concepedia

Author

Tanja Hakkarainen

Helsinki University Hospital

Also Known As

Hakkarainen Tanja, Tanja Hakkarainen

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Helsinki University Hospital University of Helsinki University of Eastern Finland University of Alabama at Birmingham University of Oulu

About

Tanja Hakkarainen is an author at Helsinki University Hospital specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	640
2	Engineering	2	2	33
3	Health Sciences	2	2	247
4	Biomedical Engineering	2	2	155
5	Biomolecular Engineering	1	1	12

Tanja Hakkarainen

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Enhanced therapeutic efficacy for ovarian cancer with a serotype 3 receptor-targeted oncolytic adenovirus Anna Kanerva, Kurt R. Zinn, Tandra R. Chaudhuri, Molecular Therapy	2003	172
Human Mesenchymal Stem Cells Lack Tumor Tropism but Enhance the Antitumor Activity of Oncolytic Adenoviruses in Orthotopic Lung and Breast Tumors Tanja Hakkarainen, Merja Särkioja, Petri Lehenkari, Human Gene Therapy Antitumor ActivityImmunologyCancer BiologyTumor BiologyViral Oncology	2007	145
Generation of a Conditionally Replicating Adenovirus Based on Targeted Destruction of E1A mRNA by a Cell Type-Specific MicroRNA Erkko Ylösmäki, Tanja Hakkarainen, Akseli Hemminki, Journal of Virology	2008	129
Cell Surface Structures Influence Lung Clearance Rate of Systemically Infused Mesenchymal Stromal Cells Johanna Nystedt, Heidi Anderson, Jonne Tikkanen, Stem Cells Cell TherapyLung InflammationImmunologyBiomedical EngineeringCellular Physiology	2012	118
Tissue-Specific Promoters Active in CD44+CD24−/low Breast Cancer Cells Gerd Bauerschmitz, Tuuli Ranki, Lotta Kangasniemi, Cancer Research	2008	109
Oncolytic Adenoviruses Kill Breast Cancer Initiating CD44+CD24–/Low Cells Minna Eriksson, Kilian Guse, Gerd Bauerschmitz, Molecular Therapy Cancer-associated VirusMedicineStem CellsImmunologyCancer Cell Biology	2007	102
Triple-Targeted Oncolytic Adenoviruses Featuring the Cox2 Promoter, E1A Transcomplementation, and Serotype Chimerism for Enhanced Selectivity for Ovarian Cancer Cells Gerd Bauerschmitz, Kilian Guse, Anna Kanerva, Molecular Therapy	2006	75
The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy Shannon Barker, Candace J. Coolidge, Anna Kanerva, The Journal of Gene Medicine	2002	69
Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses Kilian Guse, Tuuli Ranki, Martti Ala‐Opas, Molecular Cancer Therapeutics	2007	61
Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus Ilkka Liikanen, Vladia Monsurrò, Laura Ahtiainen, Molecular Therapy Oncolytic AdenovirusesInterferon Pathways MediatesTumor RecurrenceViral PathogenesisImmunology	2011	53

Page 1